Pharmacovigilance Risk Assessment Ctte. Oct 22 EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders EMA safety committee (PRAC) recommended measures to minimise risks of serious side effects associated with Janus kinase (JAK) inhibitors used to treat various chronic inflammatory disorders. Side effects include cardiovascular conditions,…
Bulgaria: improved protection from violence
Bulgaria: Improved protection from violence against women and domestic violence. https://bit.ly/3NqAIHv | Lire en français Strasbourg, 20 May 2022 – In a letter addressed to the Prime Minister and the Minister of Justice of Bulgaria published today, Council of Europe Commissioner for Human Rights, Dunja Mijatović called on the Bulgarian authorities to improve the legal…